A biosynthetic platform for microbial production of butyl butyrate esters from renewable feedstocks

Background

The field of biomanufacturing of esters, such as butyl butyrate, has gained significant attention due to the growing demand for sustainable production of chemicals used in food, fragrances, cosmetics, and biofuels. Traditionally, esters like butyl butyrate are synthesized through chemical processes such as Fischer esterification, which require harsh reaction conditions, high energy input, and expensive catalysts, leading to environmental concerns and increased production costs. As a result, there is a strong motivation to develop greener, more cost-effective biosynthetic routes that utilize renewable feedstocks like glucose and operate under milder conditions. Microbial fermentation, leveraging engineered microorganisms to convert simple sugars into valuable esters, offers a promising alternative that aligns with the principles of green chemistry and circular bioeconomy.

Despite the promise of biosynthetic approaches, current methods face several significant challenges. Enzymatic pathways for ester production, such as lipase-catalyzed esterification and alcohol acyltransferase (AAT)-mediated condensation, have been limited by low product yields, poor enzyme specificity, and the need for supplementation with expensive substrates like butanol or butyrate. Microbial hosts often struggle to co-produce the necessary alcohol and acid precursors at sufficient titers, and product inhibition or unfavorable reaction equilibria further constrain efficiency. Attempts to express esterification enzymes intracellularly have been hampered by suboptimal pH conditions and low catalytic activity, while co-culture systems introduce complexity and often fail to achieve meaningful production levels. These limitations underscore the need for innovative metabolic engineering strategies and process optimizations to overcome bottlenecks and enable economically viable, high-titer biosynthesis of esters directly from renewable resources.

Technology

This technology enables the efficient biosynthetic production of butyl butyrate (BB) directly from glucose using metabolically engineered Clostridium tyrobutyricum. The process leverages advanced metabolic engineering, including the optimization of the adhE2 gene to enhance butyraldehyde specificity and the strategic manipulation of key regulatory and pathway genes to maximize the co-production of butanol and butyrate. Two complementary strategies are implemented: an extracellular in situ esterification method and an intracellular biosynthesis method. The extracellular approach utilizes a two-phase, pH-controlled fermentation system with n-hexadecane and Tween-80 microemulsions, facilitating high-yield, lipase-catalyzed esterification of butanol and butyrate, achieving BB titers up to 71.4 g/L. The intracellular method involves chromosomal integration and overexpression of an alcohol acyltransferase (AAT) gene, enabling direct BB synthesis from glucose, with a demonstrated yield of 3.92 g/L.

What differentiates this technology is its integrated, systematic approach to overcoming the limitations of traditional chemical and earlier biosynthetic methods. The combination of precise genetic modifications, such as the F712S mutation in adhE2 and the deletion of competing pathways, with innovative process engineering—especially the use of microemulsion systems and two-phase pH control—enables unprecedented BB titers from a renewable carbon source without the need for external substrate supplementation. The use of C. tyrobutyricum as a robust chassis organism, coupled with detailed protocols for enzyme engineering and fermentation optimization, establishes a versatile platform for sustainable ester production. This approach not only reduces environmental impact and operational costs but also provides a scalable solution adaptable to the biosynthesis of a wide range of valuable esters for food, cosmetic, and fuel applications.

Benefits

• Enables high-titer production of butyl butyrate (71.4 g/L) from glucose without external substrate supplementation, enhancing sustainability and cost-effectiveness.
• Utilizes metabolically engineered *Clostridium tyrobutyricum* optimized for balanced co-production of butanol and butyrate precursors, improving biosynthetic efficiency.
• Employs innovative two-phase pH-controlled fermentation with microemulsion systems to enhance lipase-catalyzed extracellular esterification and continuous product extraction, preventing inhibition.
• Offers an intracellular biosynthesis route via chromosomal integration of alcohol acyltransferase genes, enabling direct ester synthesis from glucose.
• Reduces reliance on harsh chemical synthesis methods and expensive catalysts, promoting greener and more environmentally friendly production processes.
• Provides a versatile platform for producing other valuable esters through combined metabolic engineering and enzymatic biocatalysis strategies.
• Demonstrates advanced enzyme engineering to improve substrate specificity and metabolic flux, increasing product yield and purity.

Applications

• Green flavor and fragrance production
• Bio-based solvent manufacturing
• Renewable fuel additive synthesis
• Eco-friendly cosmetic ingredient production

Additional info

This work details processes for producing butyl butyrate from glucose using metabolically engineered *Clostridium tyrobutyricum*. Strategies include an extracellular lipase-catalyzed esterification in a two-phase microemulsion system, yielding 71.4 g/L, and an intracellular alcohol acyl transferase-mediated biosynthesis, producing 3.92 g/L. Key modifications enhance butyraldehyde specificity and balance precursor production.